Middle East Journal of Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.5 | Q4 | 5.1% | 0.192 | Q4 | 26.2% |
| 2024 | 0.4 | Q4 | 4.9% | 0.186 | Q4 | 27.8% |
| 2023 | 0.4 | Q4 | 7.1% | 0.229 | Q4 | 39.7% |
| 2022 | 0.4 | 4.9% | 0.172 | Q4 | 32.6% | |
| 2021 | — | 25.2% | 0.171 | Q4 | 34.3% | |
| 2020 | — | — | 0.227 | Q4 | 40.5% | |
| 2019 | — | — | 0.177 | Q4 | 34.1% | |
| 2018 | — | — | 0.138 | Q4 | 17.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2008-6687
ISSN
2008-6709
country
IRcoverage
2014-2026